New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmacology
Reference110 articles.
1. Efficacy of Jinhua Qinggan Granules combined with western medicine in the treatment of confirmed and suspected COVID-19: A randomized controlled trial;An;Frontiers in Medicine (Lausanne),2021
2. X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases;Báez-Santos;Journal of Medical Chemistry,2014
3. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds;Báez-Santos;Antiviral Research,2015
4. Xuebijing protects against septic acute liver injury based on regulation of GSK-3β pathway;Cao;Frontiers in Pharmacology,2021
5. Efficacy and safety of Jinhua Qinggan Granules for coronavirus disease 2019 (COVID-19): A protocol of a systematic review and Meta-analysis;Chen;Medicine (Baltimore),2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Characterization and expression analysis of the MADS-box gene family in Lonicera japonica reveals the role of LjMADS36 in flower coloration;Industrial Crops and Products;2024-11
2. Risk prediction for severe COVID-19 progressing to critical illness and death in the ICU and efficacy analysis of using traditional Chinese medicine;Medicine;2024-03-22
3. Inhibitory Efficacy of Main Components of Scutellaria baicalensis on the Interaction between Spike Protein of SARS-CoV-2 and Human Angiotensin-Converting Enzyme II;International Journal of Molecular Sciences;2024-03-02
4. Exploring the chemical components of Kuanchang-Shu granule and its protective effects of postoperative ileus in rats by regulating AKT/HSP90AA1/eNOS pathway;Chinese Medicine;2024-02-21
5. Anemoside B4 inhibits SARS-CoV-2 replication in vitro and in vivo;Chinese Herbal Medicines;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3